case_images: PMC7547347_01
case_images: This figure shows the right upper eyelid swelling and ptosis with a palpable firm mass 20 mm in diameter.
case_images: CRIOPM2020-8827074.001.jpg
case_images: PMC7547347_01_CRIOPM2020-8827074.001.jpg
case_images: fig1
case_images: Physical examination showed the right upper eyelid swelling and ptosis with a nontender palpable firm mass 20 mm in diameter (Figure 1).
case_images: (a) Computed tomography (CT) axial view. (b) Computed tomography (CT) coronal view. (a, b) An infiltrative mass at the right superolateral orbital involving the lacrimal gland and upper eyelid.
case_images: CRIOPM2020-8827074.002.jpg
case_images: PMC7547347_01_CRIOPM2020-8827074.002.jpg
case_images: fig2
case_images: Computed tomography (CT) showed an infiltrative mass at the right superolateral orbital involving the lacrimal gland and upper eyelid (Figures 2(a) and 2(b)).
case_images: A mass involving the septum and orbital fat with multiple loculated abscesses.
case_images: CRIOPM2020-8827074.003.jpg
case_images: PMC7547347_01_CRIOPM2020-8827074.003.jpg
case_images: fig3
case_images: A mass involving the septum and orbital fat with multiple loculated abscess was observed intraoperatively (Figure 3).
case_images: (a) Histopathologic section shows fungal hyphae in granulomatous inflammation background (H&E 400x). (b) Periodic acid-Schiff (PAS) (600x). (c) Grocott methenamine silver (GMS) staining (600x). (b, c) Broad nonseptate and septate hyphae with the right angle branching on PAS and GMS.
case_images: CRIOPM2020-8827074.004.jpg
case_images: PMC7547347_01_CRIOPM2020-8827074.004.jpg
case_images: fig4
case_images: Histopathology demonstrated granulomatous inflammation (Figure 4(a)) with broad nonseptate and sparsely septate hyphae with the right angle branching on periodic acid-Schiff (PAS) (Figure 4(b)) and Grocott methenamine silver (GMS) staining (Figure 4(c)) with no vascular invasion.
case_images: The patient at 3-month follow-up.
case_images: CRIOPM2020-8827074.005.jpg
case_images: PMC7547347_01_CRIOPM2020-8827074.005.jpg
case_images: fig5
case_images: At 3-month follow-up, there was complete resolution of all symptoms and signs (Figure 5).